Keating Investment Counselors Inc Pfizer Inc Transaction History

Keating Investment Counselors Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 08, 2023	BUY	$41.75 - $54.5 $245,490 - $320,460	5,880 New	5,880 $301,000
Q2 2021 Jul 29, 2021	SELL	$35.91 - $40.68 $223,144 - $252,785	-6,214 Closed	0 $0
Q1 2021 Apr 26, 2021	SELL	$33.49 - $37.77 $50,235 - $56,655	-1,500 Reduced 19.45%	6,214 $225,000
Q2 2020 Jul 22, 2020	SELL	$30.12 - $36.54 $9,036 - $10,962	-300 Reduced 3.74%	7,714 $252,000
Q1 2020 Apr 29, 2020	SELL	$27.03 - $38.62 $86,496 - $123,583	-3,200 Reduced 28.54%	8,014 $262,000
Q3 2019 Oct 28, 2019	SELL	$32.49 - $42.13 $97,470 - $126,390	-3,000 Reduced 21.11%	11,214 $403,000
Q2 2019 Aug 01, 2019	SELL	$36.98 - $41.52 $40,678 - $45,672	-1,100 Reduced 7.18%	14,214 $616,000
Q1 2019 Apr 22, 2019	SELL	$37.5 - $41.2 $21,562 - $23,690	-575 Reduced 3.62%	15,314 $650,000
Q2 2018 Aug 01, 2018	SELL	$32.98 - $35.16 $31,726 - $33,823	-962 Reduced 5.71%	15,889 $576,000
Q4 2017 Feb 14, 2018	BUY	$33.26 - $35.29 $33 - $35	1 Added 0.01%	16,851 $610,000
Q3 2017 Nov 09, 2017	SELL	$31.0 - $34.15 $12,400 - $13,660	-400 Reduced 2.32%	16,850 $602,000
Q2 2017 Aug 10, 2017	BUY	N/A	17,250	17,250 $579,000

3,218

3.71B

73.2M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $167B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Keating Investment Counselors Inc, based on Form 13F filings with the SEC.

Stay updated on Keating Investment Counselors Inc with notifications on news.